Summary
The Coca-Cola Company reported net operating revenues of $11.129 billion for the first quarter of 2025, a slight decrease of 1.5% compared to $11.300 billion in the prior year period. This revenue decline was primarily influenced by a 5% unfavorable foreign currency exchange rate impact, largely due to a stronger U.S. dollar, which offset a 5% positive impact from price, product, and geographic mix. Despite the revenue dip, consolidated net income attributable to shareowners increased to $3.330 billion from $3.177 billion, resulting in diluted earnings per share of $0.77 for both periods. The company demonstrated solid operational performance with operating income increasing by 71% to $3.659 billion, significantly boosted by lower "other operating charges" compared to the prior year's $1.573 billion. Key drivers for this improvement included favorable pricing initiatives and a reduction in non-recurring charges, such as the impairment of the BodyArmor trademark in the prior year, alongside the remeasurement of contingent consideration for the fairlife acquisition. The company also reported a robust increase in cash from financing activities, reflecting strategic debt management and share repurchases. Investors should note the ongoing significant legal and tax matters, particularly the $6.0 billion tax deposit related to the IRS tax litigation for tax years 2007-2009, for which the company is appealing. While the company believes it has strong defenses, potential future liabilities from this and other tax disputes remain a risk, with an estimated aggregate potential incremental tax and interest liability for 2010-2024 of approximately $12 billion. The company's strong balance sheet and cash flow generation provide a buffer, but continued monitoring of these contingencies is crucial.
Financial Highlights
52 data points| Revenue | $11.13B |
| Cost of Revenue | $4.16B |
| Gross Profit | $6.97B |
| SG&A Expenses | $3.23B |
| Operating Income | $3.66B |
| Interest Expense | $387.00M |
| Net Income | $3.33B |
| EPS (Basic) | $0.77 |
| EPS (Diluted) | $0.77 |
| Shares Outstanding (Basic) | 4.30B |
| Shares Outstanding (Diluted) | 4.31B |
Key Highlights
- 1Net operating revenues decreased by 1.5% to $11.129 billion, primarily impacted by unfavorable foreign currency fluctuations.
- 2Consolidated Net Income attributable to shareowners increased by 4.8% to $3.330 billion, with diluted EPS remaining stable at $0.77.
- 3Operating Income surged by 71% to $3.659 billion, largely due to a significant reduction in "Other Operating Charges" compared to the prior year.
- 4The company continues to actively manage its capital structure, with net cash provided by financing activities at $3.432 billion, supported by debt issuances and share repurchases.
- 5A significant $6.0 billion payment was made related to IRS tax litigation for the 2007-2009 tax years, with an ongoing appeal and potential future liabilities estimated at around $12 billion for subsequent years.
- 6Gross profit margin slightly improved to 62.6% due to favorable pricing and divestitures, partially offset by higher commodity costs.
- 7Unit case volume showed mixed performance across segments, with global growth at 2%, led by Asia Pacific (6%) and Europe, Middle East & Africa (3%), while North America saw a 3% decline.